نتایج جستجو برای: combination chemotherapy

تعداد نتایج: 478657  

2011
Yassir Sbitti Ismail Essaidi l Adil Debbagh Habiba Kadiri Mohamed Oukabli Yassine Moussaid Khaoula Slimani Mohamed Fetohi Hakim Elkaoui Abderrahmane Albouzidi Mohamed Mahi Abdelmounaim Ait Ali Mohamed Ichou Hassan Errihani

We report here a 44-year-old Moroccan man with resectable gastric adenocarcinoma with overexpression of human epidermal growth factor receptor 2 (HER2) by immunohistochemistry who was treated with trastuzumab in combination with chemotherapy in perioperative setting. He received 3 cycles of neoadjuvant chemotherapy consisting of trastuzumab, oxaliplatin, and capecitabine. Afterwards, he receive...

Journal: :Blood 1989
K K Hussein S Dahlberg D Head C C Waddell L Dabich J K Weick F Morrison J H Saiki E Metz S E Rivkin

The Southwest Oncology Group conducted a study of acute lymphoblastic leukemia (ALL) in adults over a 5-year period, testing the utility of the L-10M regimen initially described by the group from Memorial Sloan-Kettering Cancer Center. One hundred sixty-eight eligible patients were treated with this intensive combination chemotherapy regimen. One hundred fifteen (68%) achieved complete remissio...

Journal: :Cancer research 2005
Steve Broomfield Andrew Currie Robbert G van der Most Matthew Brown Ivonne van Bruggen Bruce W S Robinson Richard A Lake

Resection alone is rarely curative for advanced tumors, but the outcome generally improves with adjuvant therapy. We have previously shown that a combination of traditional chemotherapy (gemcitabine) and immunotherapy (anti-CD40/FGK-45) without surgery is synergistic and can lead to long-term cure when applied to small tumors. Such cured animals have immunologic memory and are protected from re...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
Danfang Zhang Eva-Maria E Hedlund Sharon Lim Fang Chen Yin Zhang Baocun Sun Yihai Cao

Chemotherapy-induced broad toxicities are the leading cause of the drug-induced mortality in cancer patients. Antiangiogenic drugs (ADs) in combination with chemotherapy are widely used as front-line therapy for the treatment of various human cancers. However, the beneficial mechanisms underlying combination therapy are poorly understood. Here we show that, in several murine tumor models, admin...

Journal: Nanomedicine Journal 2018

Objective(s): Combination anticancer therapy holds promise for improving the therapeutic efficacy of chemotherapy drugs such as doxorubicin (DOX) as well as decreasing their dose-limiting side effects. Overcoming the side effects of doxorubicin (DOX) is a major challenge to the effective treatment of cancer. Zinc oxide nanoparticles (ZnO NPs) are emerging as potent tools for a wide variety of b...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید